Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Pre-Close Trading Statement

19 Jan 2009 07:00

RNS Number : 8288L
BrainJuicer Group PLC
19 January 2009
 



Press Release

 19 January 2009

BrainJuicer Group PLC

("BrainJuicer" or "the Company")

Pre-Close Trading Statement 

Strong Full Year - Results Ahead of Expectations

BrainJuicer Group PLC, (AIM: BJU), a leading global online market research agency, is pleased to announce the following pre-close trading statement for the financial year ended 31 December 2008.  

Highlights:

Results ahead of market expectations 
Reported revenues of over £9m, (an increase of over 40%)
Operating profit up by 45% to over £1.2m 

Clients increased from 115 to 140 and from 19 to 24 of world's top 200 companies (FTSE Global 500 2008)

Innovative new products grew by more than 50% and now account for over 40% of revenue

 

The Company's revenue growth (which was entirely organic) reflected strong trading performance across each of the groups' regions, and enabled the Company to continue investing in its technology platform and to start paying dividends (the 2008 interim dividend was 0.5p per share and the Company paid an additional special dividend of 1.7p per share).

2008 saw the Company increase its geographic expansion, opening an office in Switzerland and signing a strategic licensing agreement in Australia, as well as continuing to grow its existing businesses in the UK, US and Holland. The Company has continued to innovate and deliver new and creative products to its blue chip client base. The Company announces today that it is continuing its new product development and geographic expansion by launching a Research Community product and establishing a presence in Germany and Canada, both important territories in terms of existing and potential multinational clients.

The Company's research community product (the JuicyBrains Community) is an innovative offering, and has been successfully piloted with 3 large multinationals. Research Communities are one of the fastest growing sectors in the industry.

On the back of strong demand from multinational clients, the Company is opening an office in Germany, the 3rd largest research market in the world [ESOMAR Industry Report 08]. The company has appointed Jonathan Gable as Managing Director of BrainJuicer Germany, based in Hamburg.  Jonathan has over 15 years of market research and marketing experience predominantly in multinational FMCG organisations (including Colgate-Palmolive and General Mills).

The Company has also signed a licence agreement with High Level Research Inc (HIGHLevel), a new Canadian market research agency under which it will provide the Company's products in this region. It has also been agreed that the Company will acquire HIGHLevel once pre-agreed financial targets have been achieved for a total consideration of C$900,000, providing that such targets are met by 2013. HIGHLevel is headed by William (Bill) Ratcliffe, PhD, who previously managed Millward Brown Canada and most recently served as Global Head of Consumer Insights at MediaCom. John KearonCEO of BrainJuicer, commented: "In the current economic conditions, we are pleased to have delivered ahead of expectations and to announce the launch of another innovative product and further geographic expansion of the business to service our growing number of large multinational clients. We are also delighted to welcome research professionals of the calibre of Jonathan to our team and Bill to the BrainJuicer network We believe HIGHLevel will be a great partner and we're looking forward to working closely with Bill as the relationship develops."

A full update will be provided at the Company's Final Results on 19th March 2009. An analyst briefing, given by John Kearon (CEO) and James Geddes (CFO), will be given at 9.30am on 19th March 2009 at Abchurch Communications, 5th Floor, 100 Cannon Street, London, EC4N 6EU.

- Ends -

For further information, please contact:

 

BrainJuicer plc

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000 

James Geddes, Chief Financial Officer

www.brainjuicer.com

Canaccord Adams Limited

Mark Williams / Adria Da Breo Richards

Tel: +44 (0)20 7050 6500

www.canaccordadams.com

UK media enquiries:

Abchurch Communications

Tel: +44 (0) 20 7398 7700

Heather Salmond / Jack Ballantyne

Tel: +44 (0) 20 7398 7714

jack.ballantyne@abchurch-group.com

www.abchurch-group.com 

Notes to Editors

BrainJuicer carries out quantitative online research using innovative, bespoke software to produce insightful market research for large, multinational companies, including 24 of the world's top 200 companies (FT 500 September 2008).

BrainJuicer operates in a growing sector of the US$25bn global research market, namely quantitative online research. BrainJuicer's main competitors are large traditional market research providers who have dominated the market for off-line market research, such as AC Nielsen, Millward Brown, Research International, IPSOS, GfK and Taylor Nelson Sofres.

Whilst the largest traditional research companies have developed their own online capability, BrainJuicer has a number of key attributes which have contributed to it achieving rapid growth and winning contracts with prestigious clients, including:

• Research platform that delivers greater diagnostic insight. BrainJuicer has developed tools and award-winning techniques that enable it to provide a greater level of qualitative diagnostic insight within quantitative market research. These techniques enable clients to enhance their understanding of consumer preference and help them make decisions on the best way to develop their products and services.

• Speed. BrainJuicer's automated research techniques enable it to conduct complicated studies very quickly. BrainJuicer's rapid deployment and results production, even on multi-country studies, provide clients with a speed to market advantage in the development of new products and services.

• A scaleable online-only business model. Unlike the traditional research companies who maintain both on and offline data collection capabilities, BrainJuicer is able to focus on operating a scaleable online-only business model.

To date the Group has conducted projects in over 50 countries and more than 30 languages and has established a presence in the UK, the Netherlands, the USSwitzerland and Germany.

Further information on BrainJuicer can be found at www.brainjuicer.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIFFLLLEITLIA
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.